To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:17 Issue:1 Number:4 ISSN#:2564-2537
ACE Report #13359
Ace Report Cover Osteoarthritis

No Clinical Benefit of 12 Weeks of Daily Oral Colchicine vs Placebo for Hand Osteoarthritis

How to Cite

OrthoEvidence. No Clinical Benefit of 12 Weeks of Daily Oral Colchicine vs Placebo for Hand Osteoarthritis. ACE Report. 2021;17(1):4. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)

Osteoarthritis Cartilage. 2021 Feb;29(2): 208-214.

Contributing Authors:
CR Davis Cd Ruediger KA Dyer S Lester SW Graf FPB Kroon SL Whittle CL Hill

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Sixty-four elderly patients diagnosed with hand osteoarthritis (OA) were randomized to receive 1 mg/day of colchicine (n=32) tablets or placebo tablets (n=32) for 12 weeks. The primary outcome of interest included hand pain measured using the Visual Analogue Scale (VAS), assessed at 6, 12 and 16 weeks follow-up. Secondary outcomes of interest included hand grip strength, tender and swollen joint (...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.